• 1
    Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence, mortality, and prevalence across 5 continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24: 21372150.
  • 2
    Bach PB,Cramer LD,Warren JL,Begg CB. Racial differences in the treatment of early stage lung cancer. N Engl J Med. 1999; 341: 11981205.
  • 3
    Clegg LX,Li FP,Hankey BF,Chu E,Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology and End Results) Program population-based study. Arch Intern Med. 2002; 162: 19851993.
  • 4
    Shavers VL,Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334357.
  • 5
    Bach PB,Schrag D,Brawley OW,Galaznik A,Yakren S,Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 21062113.
  • 6
    Wisnivesky JP,McGinn T,Henschke C,Hebert P,Iannuzzi MC,Halm EA. Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med. 2005; 11581163.
  • 7
    Schwatrz KL,Crossley-May H,Vigneau FD,Brown K,Banerjee M. Race, socioeconomic status and stage at diagnosis for 5 common malignancies. Cancer Causes Control. 2003; 14: 761766.
  • 8
    Potosky AL,Saxman S,Wallace RB,Lynch CF. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol. 2004; 22: 32613268.
  • 9
    Lathan CS,Neville BA,Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006; 24: 413418.
  • 10
    McCann J,Artinian V,Duhaime L,Lewis JWJr,Kvale PA,DiGiovine B. Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest. 2005; 128: 34403446.
  • 11
    Margolis ML,Christie JD,Silvestri GA,Kaiser L,Santiago S,Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003; 139: 558563.
  • 12
    Woods LM,Rachet B,Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006; 17: 519.
  • 13
    Ou SI,Zell JA,Ziogas A,Anton-Culver H. Epidemiology of nasopharyngeal carcinoma (NPC) in California: survival advantage of Chinese WHO type 1 NPC patients resulted in Asian ethnicity as an independent and favorable prognostic factor of survival for NPC patients as a whole and for patients with the WHO histologic type 1. J Clin Oncol. 2006; 24(18S): 283S. Abstract 5514.
  • 14
    Zell JA,Cinar P,Mobasher M,Ziogas A,Meyskens FL,Anton-Culver H. The effects of race, socioeconomic status, and treatment on survival for invasive cutaneous melanoma cases. J Clin Oncol. 2008; 26: 6675.
  • 15
    Zell JA,Rhee JM,Ziogas A,Lipkin SM,Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007; 16: 546552.
  • 16
    Parikh-Patel A,Bates JH,Campleman S. Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988–2000. Cancer. 2006; 107( 5 suppl): 11891195.
  • 17
    California Cancer Registry. How complete are California Cancer Registry data? Available from:, 2006 Accessed on May 5, 2006.
  • 18
    Zell JA,Ou S-HI,Ziogas A,Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005; 23: 83968405.
  • 19
    Zell JA,Ou S-HI,Ziogas A,Anton-Culver H. Long-term survival difference for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol. 2006; 17: 12551262.
  • 20
    Yost K,Perkins C,Cohen R,Morris C,Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001; 12: 703711.
  • 21
    Blackstock AW,Herndon JE,Paskett ED, et al. Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B. J Natl Cancer Inst. 2002; 94: 284290.
  • 22
    Greenwald HP,Polissar NL,Borgatta EF,McCorkle R,Goodman G. Social factors, treatment, and survival in early stage non-small cell lung cancer. Am J Public Health. 1998; 8: 16811684.
  • 23
    Battafarano RJ,Piccirillo JF,Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002; 123: 280287.
  • 24
    Moro-Sibilot D,Aubert A,Diab S, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J. 2005; 26: 480486.
  • 25
    Firat S,Bousamra M,Gore E,Byhardt RW. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002; 52: 10471057.
  • 26
    Goodwin JS,Hunt WC,Key CR,Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987; 258: 31253130.
  • 27
    Greenberg ER,Chute CG,Stukel T, et al. Social and economic factors in the choice of lung cancer treatment. A population-based study in 2 rural states. N Engl J Med. 1988; 318: 612617.
  • 28
    Ganz PA,Lee JJ,Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer. 1991; 67: 31313135.
  • 29
    Saito-Nakaya K,Nakaya N,Fujimori M, et al. Marital status, social support and survival after curative resection in non-small-cell lung cancer. Cancer Sci. 2006; 97: 206213.
  • 30
    Fujisawa T,Lizasa T,Saitoh Y, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small cell lung carcinomas. J Clin Oncol. 1999; 17: 20862091.
  • 31
    Wu YC,Lin CF,Hsu WH,Huang BS,Huang MH,Wang LS. Long term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg. 2003; 24: 9941001.
  • 32
    Barbeau EM,Krieger N,Soobader MJ. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004; 94: 269278.
  • 33
    Tammemagi CM,Neslund-Dudas C,Simoff M,Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turns predicts treatment and survival. J Clin Epidemiol. 2004; 57: 597609.
  • 34
    Gordon HS,Street RLJr,Sharf BF,Kelly A,Souchek J. Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol. 2006; 24: 904909.
  • 35
    The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT scanning. N Engl J Med. 2006; 355: 17631771.